Treatment sequencing and independent outcomes of first- and second-line chemotherapy in a retrospective series of patients with biliary tract cancer

HIGHLIGHTS

• What: In ourhave paper, the authors propose an exploratory investigation of the relevance of treatment Four patients were not included due to the were not included due to the following reasons: one patient was treated with first-line following reasons: one patient was treated with first-line Atezolizumab/bevacizumab Atezolizumab/bevacizumab combination, and three patients were treated with first-line combination, three patients single-agentand CTX . The authors report a retrospective series of long-term surviving patients with BTC treated recently, theof GemCis combination was considered the best first-line therapeutic with Until at least three lines . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.